PRKACA antibody
Quick Overview for PRKACA antibody (ABIN5701212)
Target
See all PRKACA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Immunogen
- protein kinase, cAMP-dependent, catalytic, alpha
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB : 1:200-1:2000 IP : 1:200-1:2000 IHC : 1:20-1:200
-
Comment
-
human testis tissue were subjected to SDS PAGE followed by western blot with FNab06478(PRKACA antibody) at dilution of 1:500
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Alternative Name
- PKA C-alpha
-
Background
- PRKACA, also named as PKACA and PKA C-alpha, belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family and cAMP subfamily. It phosphorylates a large number of substrates in the cytoplasm and the nucleus. This antibody is specific to PRK
-
Molecular Weight
- 41kDa
-
UniProt
- P17612
-
Pathways
- NF-kappaB Signaling, Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-